Announcements

The Foundation’s Role in Advancing Medical Product Development in the United States
Read More
Maintaining America's Leadership in Biomedical Innovation: FDA's Role in Advancing U.S. Drug Development Written Testimony
Maintaining America's Leadership in Biomedical Innovation: FDA's Role in Advancing U.S. Drug Development Written Testimony
Read More
Call for Nominations for the 2026 Innovations in Regulatory Science & Policy Awards
The Reagan-Udall Foundation for the FDA invites nominations for its annual Innovations in Regulatory Science & Policy Awards.
Read More
More Announcements

Coverage

EpochTV Live: Public Meeting Examines Drug Repurposing for New Treatment Options
Hosted by the Reagan-Udall Foundation for the FDA, the meeting brings together representatives from federal agencies, clinicians, researchers, and patient organizations to discuss approaches for identifying promising drug repurposing candidates for…
Read More
Palvella Therapeutics: Palvella Therapeutics Chief Scientific Officer Jeff Martini, Ph.D. Selected to Present at Upcoming FDA Public Workshop on Drug Repurposing
Hybrid public meeting on August 5th will explore approaches to selecting and prioritizing promising FDA-approved drugs for repurposing, with the potential to accelerate patient access to effective therapies for significant unmet medical needs.
Read More
Spencer Fane: FDA Leadership Provides Revised Priorities at Reagan-Udall Foundation Annual Board of Directors Meeting
On July 21, the Reagan-Udall Foundation for the Food and Drug Administration held its 2026 Annual Public Meeting of the Board of Directors.
Read More
More Coverage